Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH is a complex chemical compound that consists of multiple amino acids and carbohydrate molecules. It features an FMOC (fluorenylmethyloxycarbonyl) protecting group, followed by L-THR (L-threonine) and BETA-D-GLCNAC(AC)3 (N-acetyl-D-glucosamine with three acetyl groups), and concludes with a carboxylic acid group (-OH). This intricate structure endows it with the potential for diverse interactions within biological systems, positioning it as a molecule of interest in the fields of biochemistry and pharmaceuticals for its therapeutic applications.

160168-40-1

Post Buying Request

160168-40-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

160168-40-1 Usage

Uses

Used in Biochemical Research:
FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH is used as a research tool for studying the interactions of complex molecules with biological systems due to its unique composition and structural features.
Used in Pharmaceutical Development:
In the pharmaceutical industry, FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH is utilized as a potential therapeutic agent for the development of treatments targeting various diseases and conditions, leveraging its capacity to engage with biological molecules.
Used in Drug Synthesis:
FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH serves as a building block in the synthesis of pharmaceutical compounds, contributing to the creation of new drugs with specific therapeutic properties.
Used in Diagnostic Applications:
FMOC-L-THR(BETA-D-GLCNAC(AC)3)-OH may also be employed in diagnostic applications, potentially aiding in the detection and monitoring of certain health conditions through its interactions with biological markers.

Check Digit Verification of cas no

The CAS Registry Mumber 160168-40-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,1,6 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 160168-40:
(8*1)+(7*6)+(6*0)+(5*1)+(4*6)+(3*8)+(2*4)+(1*0)=111
111 % 10 = 1
So 160168-40-1 is a valid CAS Registry Number.

160168-40-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3R)-3-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxy methyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy) carbonyl]amino}butanoic acid (non-preferred name)

1.2 Other means of identification

Product number -
Other names GALNAC L-THREONINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:160168-40-1 SDS

160168-40-1Relevant articles and documents

Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy

Li, Yulei,Zhang, Yihan,Wu, Minghao,Chang, Qi,Hu, Honggang,Zhao, Xia

, p. 516 - 525 (2019/03/11)

As a host defense peptide, hymenochirin-1B has attracted increasing attention for its strong cytotoxic activities. However, its poor selectivity and proteolytic stability remain major obstacles for clinical application. To solve these problems, we designed and synthesized a series of peptide analogues of hymenochirin-1B based on cationic residue substitution and stapling combined with a glycosylation strategy. Some analogues showed improvement not only in selectivity and proteolytic stability but also in antitumor activity. Among them, the glycosylated stapled peptide H-58 was identified as the most potential antitumor peptide. Flow cytometry and a competitive binding assay revealed that H-58 displayed significant antitumor selectivity. Confocal microscopy and nuclear staining with Hoechst dye demonstrated that H-58 entered the nucleus and caused DNA damage. In summary, the strategy of glycosylated stapled peptides is a promising approach for improving the antitumor selectivity, proteolytic stability, and antitumor activity of hymenochirin-1B, which can be used for other bioactive peptide modifications.

Simple and Efficient Preparation of O- and S-GlcNAcylated Amino Acids through InBr3-Catalyzed Synthesis of β- N-Acetylglycosides from Commercially Available Reagents

De Leon, Cesar A.,Lang, Geoffrey,Saavedra, Marcos I.,Pratt, Matthew R.

supporting information, p. 5032 - 5035 (2018/08/24)

The facile synthesis of serine, threonine, and cysteine β-glycosides using commercially available peracetylated β-N-acetylglucosamine (β-Ac4GlcNAc) and catalytic amounts of indium bromide (InBr3) is described. This method involves only inexpensive reagents that require no further modification or special handling. The reagents are simply mixed, dissolved, and refluxed to afford the GlcNAcylated amino acids in great yields (70-80%). This operationally simple procedure should facilitate the study of O-GlcNAcylation without necessitating expertise in synthetic carbohydrate chemistry.

Divergent behavior of glycosylated threonine and serine derivatives in solid phase peptide synthesis

Zhang, Yalong,Muthana, Saddam M.,Barchi, Joseph J.,Gildersleeve, Jeffrey C.

supporting information; experimental part, p. 3958 - 3961 (2012/10/18)

Solid phase peptide coupling of glycosylated threonine derivatives was systematically evaluated. In contrast to glycosylated serine derivatives which are highly prone to epimerization, glycosylated threonine derivatives produce only negligible amounts of epimerization. Under forcing conditions, glycosylated threonine analogs undergo β-elimination, rather than epimerization. Mechanistic studies and molecular modeling were used to understand the origin of the differences in reactivity. This article not subject to U.S. Copyright. Published 2012 by the American Chemical Society.

Practical synthesis of the 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucosides of Fmoc-serine and Fmoc-threonine and their benzyl esters

Carvalho, Ivone,Scheuerl, Shona L.,Kartha, K.P. Ravindranathan,Field, Robert A.

, p. 1039 - 1043 (2007/10/03)

Mercuric bromide-promoted glycosylation of Fmoc-Ser-OBn and Fmoc-Thr-OBn with 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-glucopyranosyl chloride in refluxing 1,2-dichloroethane gave the corresponding β-glycosides in good yields (64 and 62%, respectively).

Building Blocks for Solid-phase Glycopeptide Synthesis: 2-Acetamido-2-deoxy-β-D-glycosides of FmocSerOH and FmocThrOH

Arsequell, Gemma,Krippner, Lorely,Dwek, Raymond A.,Wong, Simon Y. C.

, p. 2383 - 2384 (2007/10/02)

A convenient and optimized synthesis of 2-acetamido-2-deoxy-β-D-glycosides of FmocSerOH and FmocThrOH, building blocks for solid-phase synthesis of glycopeptides containing GlcNAc β-linked to Ser or Thr, is for the first time established.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 160168-40-1